|
Yale Cancer Center NCTN
|
3U10CA180826-03S1
|
$49,901
|
$2,495
|
HOCHSTER, HOWARD
|
YALE UNIVERSITY
|
|
Yale Cancer Center NCTN
|
5U10CA180826-04
|
$951,500
|
$47,575
|
HOCHSTER, HOWARD
|
YALE UNIVERSITY
|
|
Winship Cancer Institute, National Clinical Trials Network Lead Academic Particip
|
5U10CA180864-04
|
$542,798
|
$20,355
|
RAMALINGAM, SURESH
|
EMORY UNIVERSITY
|
|
Vanderbilt Network Lead Academic Participating Site for the NCTN
|
5U10CA180847-05
|
$592,247
|
$29,612
|
BERLIN, JORDAN
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-43S1
|
$125,000
|
$8,750
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-43S2
|
$31,772
|
$2,224
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive Cancer Center Support
|
5P30CA014520-43
|
$4,288,496
|
$300,195
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UT Southwestern NCI National Clinical Trials Network Lead Academic Site - U10
|
3U10CA180870-03S1
|
$50,000
|
$1,250
|
GERBER, DAVID
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
UT Southwestern NCI National Clinical Trials Network Lead Academic Site - U10
|
5U10CA180870-04
|
$700,000
|
$17,500
|
GERBER, DAVID
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
UT MD Anderson Cancer Center Network Lead Academic Participating Site (LAP)
|
5U10CA180858-04
|
$688,299
|
$17,207
|
ENG, CATHY
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Urologic Oncology Research Training Grant
|
5T32CA082088-18
|
$292,379
|
$43,857
|
CARVER, BRETT
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Urologic Oncology Branch Consult Core
|
ZID BC 011092
|
$1,788,723
|
$1,252,106
|
Linehan, W. Marston
|
CCR (NCI)
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-28S3
|
$6,166,044
|
$61,660
|
FEARON, ERIC
|
UNIVERSITY OF MICHIGAN
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-28S4
|
$50,000
|
$500
|
FEARON, ERIC
|
UNIVERSITY OF MICHIGAN
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-28S5
|
$30,973
|
$310
|
FEARON, ERIC
|
UNIVERSITY OF MICHIGAN
|
|
University of Colorado NTCN Lead Academic Participating Site (LAPS)
|
5U10CA180834-04
|
$768,950
|
$38,448
|
ELIAS, ANTHONY
|
UNIVERSITY OF COLORADO DENVER
|
|
Understanding T Cell Rapamycin Resistance
|
ZIA BC 011220
|
$272,402
|
$54,480
|
Fowler, Daniel
|
CCR (NCI)
|
|
UM LAPs- U10 Grant
|
5U10CA180801-04
|
$803,208
|
$40,160
|
ZALUPSKI, MARK
|
UNIVERSITY OF MICHIGAN
|
|
UCDCCC NCTN U10 Program
|
5U10CA180846-04
|
$592,771
|
$14,819
|
GANDARA, DAVID
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
|
Tumor Microenvironment in Cancer Progression
|
ZIA BC 011332
|
$474,811
|
$9,496
|
Kaplan, Rosandra
|
CCR (NCI)
|
|
Translational Surgical Pathology
|
ZIE SC 000853
|
$192,132
|
$76,853
|
Merino, Maria
|
CCR (NCI)
|
|
Tissue Processing-Sequencing Facility
|
ZIC BC 011044
|
$651,382
|
$325,691
|
Vocke, Cathy
|
CCR (NCI)
|
|
The University of Texas Southwestern Medical Center SPORE in Kidney Cancer
|
5P50CA196516-02
|
$2,300,000
|
$2,300,000
|
BRUGAROLAS, JAMES
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
The tumor suppressive role of PBRM1, the bromodomain-containing subunit of the PBAF chromatin remodeling complex
|
1U01CA207532-01A1
|
$349,399
|
$349,399
|
DYKHUIZEN, EMILY
|
PURDUE UNIVERSITY
|
|
The targeting of the HIF switch in kidney cancer
|
7R01CA181106-04
|
$404,838
|
$404,838
|
KOH, MEI YEE
|
UNIVERSITY OF UTAH
|
|
The Role of the miRNA Cluster at 14q32 in Lipid Regulation and Renal Cancer Biology
|
1R03CA212696-01A1
|
$74,750
|
$74,750
|
NANJUNDAN, MEERA
|
UNIVERSITY OF SOUTH FLORIDA
|
|
The role of PLAG1 in Wilms tumor formation
|
1K08CA207849-01A1
|
$157,185
|
$157,185
|
CHEN, KENNETH
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
The Role of NDUFA4L2 in Clear Cell Renal Cell Carcinoma
|
1F31CA213814-01
|
$44,044
|
$44,044
|
KUBALA, JACLYN
|
WEILL MEDICAL COLL OF CORNELL UNIV
|
|
The role of Lin28/let 7 pathway in Wilms' tumor
|
5F99CA212487-02
|
$31,994
|
$31,994
|
YERMALOVICH, ALENA
|
HARVARD UNIVERSITY
|
|
The Role of Fgf Signaling in Vertebrate Development
|
ZIA BC 010338
|
$384,245
|
$76,849
|
Lewandoski, Mark
|
CCR (NCI)
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-23S1
|
$204,369
|
$6,131
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-23S2
|
$57,797
|
$1,734
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-23S3
|
$79,482
|
$2,384
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
5P30CA060553-23
|
$4,865,652
|
$145,970
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The Obesity Paradox in Renal Cell Carcinoma
|
5R03CA195098-02
|
$84,825
|
$84,825
|
WILSON, KATHRYN
|
HARVARD SCHOOL OF PUBLIC HEALTH
|
|
The Impact of Mitochondrial Repression and Lipid Accumulation by HIF on Tumor Growth
|
5R35CA197713-03
|
$767,523
|
$767,523
|
GIACCIA, AMATO
|
STANFORD UNIVERSITY
|
|
The function of Snf5, an epigenetic tumor suppressor
|
5R01CA113794-14
|
$369,757
|
$369,757
|
ROBERTS, CHARLES
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
The effect of cancer-associated SETD2 mutations on transcription and chromatin organization
|
5F30CA192643-03
|
$39,712
|
$39,712
|
FAHEY, CATHERINE
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Targeting Kidney Cancer-associated CD105 expression with a novel Listeria-based Vaccine Approach
|
1R15CA216205-01
|
$376,776
|
$376,776
|
WOOD, LAURENCE
|
TEXAS TECH UNIVERSITY HEALTH SCIS CENTER
|
|
Targeting glycocalyx-mediated mechanisms of tumor metastasis
|
1R01CA204949-01A1
|
$471,731
|
$471,731
|
MUNN, LANCE
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Targeting Genetic and Metabolic Alterations in Distinct Subtypes of RCC
|
ZIA BC 011648
|
$532,928
|
$532,928
|
Srinivasan, Ramaprasad
|
CCR (NCI)
|
|
Synthetic lethality in VHL tumor suppressor null tumors
|
5R03CA202563-02
|
$70,703
|
$70,703
|
RAZORENOVA, OLGA
|
UNIVERSITY OF CALIFORNIA-IRVINE
|
|
SWOG Network Group Operations Center of the NCTN
|
3U10CA180888-04S1
|
$894,348
|
$17,887
|
BLANKE, CHARLES
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
SWOG Network Group Operations Center of the NCTN
|
5U10CA180888-04
|
$7,617,946
|
$152,359
|
BLANKE, CHARLES
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
Studying metabolic stress signaling in renal cancer
|
5R01CA181196-04
|
$1
|
$1
|
GAN, BOYI
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Study of Tumor Pathogenesis and Development of Therapies for AIDS Malignancies
|
ZIA BC 010885
|
$924,476
|
$92,448
|
Yarchoan, Robert
|
CCR (NCI)
|
|
Study of Hereditary Renal and Other Familial Syndromes
|
ZIA BC 010696
|
$256,176
|
$153,706
|
Merino, Maria
|
CCR (NCI)
|
|
Studies of the Antifungal Drug Itraconazole As A Novel Inhibitor of Angiogenesis
|
5R01CA184103-03
|
$370,575
|
$185,288
|
LIU, JUN
|
JOHNS HOPKINS UNIVERSITY
|
|
Stanford University NCTN- Network Lead Academic Site
|
5U10CA180816-04
|
$547,394
|
$13,685
|
WAKELEE, HEATHER
|
STANFORD UNIVERSITY
|
|
Stanford Cancer Institute
|
5P30CA124435-10
|
$3,338,488
|
$100,155
|
MITCHELL, BEVERLY
|
STANFORD UNIVERSITY
|
Total relevant funding to Kidney Disease for this search: $47,723,327
|